SNSE
Sensei Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.85
−22.28%Latest reported
- Last report date
- May 15, 2026
- EPS actual
- -$131
- EPS estimate
- -$0.62
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -5266.9%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $58
- PT range
- $55 – $60
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 15, 2026